Sinonasal Malignancies: Pathology Nuances and Therapeutic Advances
16th February, 2024, 16:00 - 17:00
M301
This session will explore the rapid evolution of the diagnostic and molecular landscape of sinonasal cancers, which has implications for treatment selection.
Objectives
At the conclusion of this session, attendees will be able to:
- Discuss the updated WHO classification of sinonasal cancers.
- Review evidence based indications for induction chemotherapy sinonasal cancers.
- Discuss current clinical trials, recent advances in biomarker discovery and implications for future therapies.
Current Schedule
As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names
| Speaker | Title | Role | Times |
|---|---|---|---|
| Christopher Farrell 215-503-7005 |
Moderator | - | |
| Glenn Hanna 6176323090 |
Moderator | - | |
| Snjezana Dogan 2126394878 |
Updates in WHO Classification of Sinonasal Malignancies | Speaker | 4:00 pm - 4:12 pm |
| Lisa Rooper 4109553580 |
Beyond Pathology Classification – Recent Discoveries in Genomics and Biomarkers | Speaker | 4:12 pm - 4:24 pm |
| Neal Akhave 832-292-5971 |
Induction Chemotherapy – What are the Indications? | Speaker | 4:24 pm - 4:36 pm |
| Glenn Hanna 6176323090 |
Current Clinical Trials in Sinonasal Malignancies and Future Directions | Speaker | 4:36 pm - 4:48 pm |
| |
Q&A | 4:48 pm - 5:00 pm |